![Jerome Bailey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historial de carrera de Jerome Bailey
Antiguos cargos conocidos de Jerome Bailey.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
LONGEVERON INC. | Director de Operaciones | 15/09/2022 | 01/04/2024 |
CHECKMATE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Formación de Jerome Bailey.
Rutgers State University of New Jersey | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 3 |
Francia | 2 |
Operativa
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
LONGEVERON INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Checkmate Pharmaceuticals, Inc.
![]() Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jerome Bailey
- Experiencia